Schematic illustration depicting the potential anti-inflammatory effects of hypolipidemic agents primarily targeting LDL-C reduction

Schematic illustration depicting the potential anti-inflammatory effects of hypolipidemic agents primarily targeting LDL-C reduction. (A). Typically, HMGCR facilitates the activation of TLRs, which subsequently triggers the expression of inflammasome-related genes through the NF-kB signaling pathway. This leads to inflammasome formation and the activation of caspase-1 protein, resulting in the maturation of several pro-inflammatory cytokines, including TNF-a. TNF-a promotes the adhesion of various molecules, such as VCAM-1 and E-selectin, contributing to endothelial dysfunction. Statins may exert anti-inflammatory effects either by inhibiting HMGCR or by enhancing the expression of PXR, a receptor commonly found in the vasculature. Activation of PXR reduces the expression of these adhesion molecules, thus promoting vascular detoxification and reducing vascular inflammation. (B). PCSK9 increases the expression of VEGF-A and ICAM-1 adhesion molecules, which leads to the migration of monocytes and macrophages, thereby boosting the production of pro-inflammatory cytokines and causing endothelial dysfunction. Silencing PCSK9 may counteract these effects. (C). Bempedoic acid exerts its anti-inflammatory effects primarily by upregulating AMPK, which subsequently reduces the activation of MAPK pro-inflammatory pathways. Additionally, bempedoic acid may improve the inflammatory environment by decreasing the production of prostaglandin E2 through the inhibition of ACLY. Abbreviations: ACLY, ATP-citrate lyase; AMPK, AMP-activated protein kinase; BA, bempedoic acid; HMGCR, 3-hydroxy-3-methylglutaryl-CoA reductase; ICAM-1, intercellular adhesion molecule-1; LDL-C, low-density lipoprotein cholesterol; MAPK, mitogen-activated protein kinase; NF-kB, nuclear factor kappa B; PCSK9, proprotein convertase subtilisin/kexin type 9; PCSK9 i, proprotein convertase subtilisin/kexin type 9 inhibitor; PXR, pregnane X receptor; TLR, toll-like receptors; TNF-α, tumor necrosis factor-alpha; VCAM-1, vascular cell adhesion molecule-1; VEGF-A, vascular endothelial growth factor A. Created with www.BioRender.com. (assessed on 14 July 2024)
Schematic illustration depicting the potential anti-inflammatory effects of hypolipidemic agents primarily targeting LDL-C reduction

Publication

The Pleiotropic Effects of Lipid-Modifying Interventions: Exploring Traditional and Emerging Hypolipidemic Therapies (2024) Dimitris Kounatidis, et al. Metabolites. 2024 Jul;14(7). Figure: F1.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates TLR TLR famplex_relations TLR1 7096
Homo sapiens Primates TLR TLR famplex_relations TLR2 7097
Homo sapiens Primates TLR TLR famplex_relations TLR3 7098
Homo sapiens Primates TLR TLR famplex_relations TLR4 7099
Homo sapiens Primates TLR TLR famplex_relations TLR5 7100
Homo sapiens Primates TLR TLR famplex_relations TLR6 10333
Homo sapiens Primates TLR TLR famplex_relations TLR7 51284
Homo sapiens Primates TLR TLR famplex_relations TLR8 51311
Homo sapiens Primates TLR TLR famplex_relations TLR9 54106
Homo sapiens Primates TLR TLR famplex_relations TLR10 81793
Homo sapiens Primates NLRP3 NLRP3 ncbigene_symbol NLRP3 114548
Homo sapiens Primates HMGCR HMGCR ncbigene_symbol HMGCR 3156
Homo sapiens Primates NF-kB NF-KB ncbigene_synonym NFKB1 4790
Homo sapiens Primates STOP STOP ncbigene_synonym MAP6 4135
Homo sapiens Primates PXR PXR ncbigene_synonym NR1I2 8856
Homo sapiens Primates Caspase CASPASE famplex_relations CASP1 834
Homo sapiens Primates Caspase CASPASE famplex_relations CASP2 835
Homo sapiens Primates Caspase CASPASE famplex_relations CASP4 837
Homo sapiens Primates Caspase CASPASE famplex_relations CASP5 838
Homo sapiens Primates Caspase CASPASE famplex_relations CASP6 839
Homo sapiens Primates Caspase CASPASE famplex_relations CASP8 841
Homo sapiens Primates Caspase CASPASE famplex_relations CASP9 842
Homo sapiens Primates Caspase CASPASE famplex_relations CASP10 843
Homo sapiens Primates Caspase CASPASE famplex_relations CASP12 100506742
Homo sapiens Primates Caspase CASPASE famplex_relations CASP14 23581
Homo sapiens Primates Caspase CASPASE famplex_relations CASP3 836
Homo sapiens Primates Caspase CASPASE famplex_relations CASP7 840
Homo sapiens Primates VCAM-1 VCAM1 ncbigene_symbol VCAM1 7412
Homo sapiens Primates TNF-a TNF-A ncbigene_synonym TNF 7124
Homo sapiens Primates AMPK AMPK ncbigene_synonym PRKAA1 5562
Homo sapiens Primates AMPK AMPK ncbigene_synonym PRKAA2 5563
Homo sapiens Primates AMPK AMPK ncbigene_synonym PRKAB1 5564
Homo sapiens Primates AMPK AMPK famplex_relations PRKAB2 5565
Homo sapiens Primates AMPK AMPK famplex_relations PRKAG1 5571
Homo sapiens Primates AMPK AMPK famplex_relations PRKAG2 51422
Homo sapiens Primates AMPK AMPK famplex_relations PRKAG3 53632
Homo sapiens Primates IL-1, IL-1 ncbigene_synonym IL1B 3553
Homo sapiens Primates IL-6, IL-6 ncbigene_synonym IL6 3569
Homo sapiens Primates ACLY ACLY ncbigene_symbol ACLY 47
Homo sapiens Primates ICAM-1 ICAM1 ncbigene_symbol ICAM1 3383
Homo sapiens Primates MAPK) MAPK famplex_relations MAPK1 5594
Homo sapiens Primates MAPK) MAPK famplex_relations MAPK3 5595
Homo sapiens Primates MAPK) MAPK famplex_relations MAPK11 5600
Homo sapiens Primates MAPK) MAPK famplex_relations MAPK12 6300
Homo sapiens Primates MAPK) MAPK famplex_relations MAPK13 5603
Homo sapiens Primates MAPK) MAPK famplex_relations MAPK14 1432
Homo sapiens Primates MAPK) MAPK famplex_relations MAPK8 5599
Homo sapiens Primates MAPK) MAPK famplex_relations MAPK9 5601
Homo sapiens Primates MAPK) MAPK famplex_relations MAPK10 5602
Homo sapiens Primates PCSK9 PCSK9 ncbigene_symbol PCSK9 255738
Homo sapiens Primates VEGF-A VEGFA ncbigene_symbol VEGFA 7422

Chemical mentions

Word Match MeSH Name ChEBI
TNF-a TNF-a chebi:197439
TNF-a TNF-a chebi:197439
PGE2 PGE2 (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid chebi:15551

Disease mentions

Word Match MeSH Name DOID